Visits: 2461, Avg visit time (secs): 286,06 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 1029 | 41,81% | |
| /lilly/programme/efsd-cds-lilly-rfa09.html | 217 | 8,82% |
| /programmes.html | 201 | 8,17% |
| /lilly/programme/efsd-lilly-rfa09.html | 156 | 6,34% |
| /lifescan/efsd-lifescan-rfa09.html | 110 | 4,47% |
| /lilly/programme/efsd-cds-lilly-rfa08.html | 105 | 4,27% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 54 | 2,19% |
| /home.html | 41 | 1,67% |
| /msd/albert-renold/efsd-msd-arenold.html | 40 | 1,63% |
| /pfizer/efsd-pfizer-rfa09.html | 40 | 1,63% |
| /novartis/efsd-novartis-rfa09.html | 39 | 1,58% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1108 | 45,02% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa09.html | 359 | 14,59% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 141 | 5,73% |
| /efsd-jdrf-novo/efsd-jdrf-novo-rfa08.html | 80 | 3,25% |
| /home.html | 71 | 2,89% |
| /msd/albert-renold/efsd-msd-arenold.html | 62 | 2,52% |
| /lifescan/efsd-lifescan-rfa09.html | 56 | 2,28% |
| /msd/clinical/efsd-msd-clinical-rfa10.html | 47 | 1,91% |
| /recipients.html | 34 | 1,38% |
| /amylin/efsd-amylin-rfa09.html | 31 | 1,26% |
| /pfizer/efsd-pfizer-rfa09.html | 31 | 1,26% |